5-ethyl-5-phenylhydantoin,
5-phenyl-5-ethylhydantoin,
desmethylmephenytoin,
ethylphenylhydantoin,
ethylphenylhydantoin, (+-)-isomer,
ethylphenylhydantoin, (R)-isomer,
ethylphenylhydantoin, (S)-isomer,
ethylphenylhydantoin, 4-(11)C-labeled,
nirvanol,
normephenytoin,
Nirvanol,
5-Ethyl-5-phenylhydantoin,
631-07-2,
Ethylphenylhydantoin,
5-ethyl-5-phenylimidazolidine-2,4-dione,
normephenytoin,
5-Phenyl-5-ethylhydantoin,
Hydantoin, 5-ethyl-5-phenyl-,
2,4-Imidazolidinedione, 5-ethyl-5-phenyl-,
desmethylmephenytoin,
(+-)-Nirvanol,
(+/-)-Nirvanol,
NSC 150466,
NSC 33388,
(+-)-5-Ethyl-5-phenylhydantoin,
EINECS 211-150-3,
2216-93-5,
rac N-Desmethyl Mephenytoin,
5-ethyl-5-phenyl-hydantoin,
5-Ethyl-5-phenyl-2,4-imidazolidinedione,
Hydantoin, 5-ethyl-5-phenyl-, (+-)-,
(+/-)-5-ETHYL-5-PHENYLHYDANTOIN,
5-Ethyl-5-phenyl-imidazolidine-2,4-dione,
CHEBI:79441,
UDTWZFJEMMUFLC-UHFFFAOYSA-N,
2,4-Imidazolidinedione, 5-ethyl-5-phenyl-, (+-)-,
MFCD00022401,
d-Nirvanol,
l-Nirvanol,
(R)-Nirvanol,
(S)-Nirvanol,
Nirvanol, L-,
(+)-Nirvanol,
(-)-Nirvanol,
(5R)-5-ethyl-5-phenylimidazolidine-2,4-dione,
l-5-Ethyl-5-phenylhydantoin,
(+)-5-Ethyl-5-phenylhydantoin,
(-)-5-Ethyl-5-phenylhydantoin,
ethylphenylhydantoin, (R)-isomer,
ethylphenylhydantoin, (S)-isomer,
BRN 0085311,
BRN 0085312,
Hydantoin, 5-ethyl-5-phenyl-, (+)-,
Hydantoin, 5-ethyl-5-phenyl-, (-)-,
ethylphenylhydantoin, (+-)-isomer,
(R)-5-Ethyl-5-phenyl-2,4-imidazolidinedione,
(S)-5-Ethyl-5-phenyl-2,4-imidazolidinedione,
AC1Q6LYG,
S-(+)-N-Desmethylmephentoin ((S)-(+)-Nirvanol),
2, 5-ethyl-5-phenyl-,
AC1L3M5V,
AC1Q2SQ6,
CHEMBL1438,
Oprea1_300355,
Oprea1_683047,
SCHEMBL2191989,
(?)-5-Ethyl-5-phenylhydantoin,
HMS1680D20,
NSC33388,
NSC-33388,
NSC150466,
STK285748,
STL309598,
AKOS000263617,
AKOS016046645,
AKOS022104892,
( inverted exclamation markA)-Nirvanol,
MCULE-8785578146,
NE37892,
NSC-150466,
TRA0100866,
VZ30300,
NCGC00165925-01,
AC-16032,
BAS 00331035,
LS-76195,
LS-76196,
LS-76197,
LS-76198,
DB-054407,
FT-0632677,
FT-0641025,
FT-0666172,
ST45138247,
5-Ethyl-5-phenyl-1h-imidazolidin-2,4-dione,
EN300-04353,
(RS)-5-Ethyl-5-phenyl-2,4-imidazolidinedione,
5-ethyl-5-phenyl-1,3-diazolidine-2,4-dione,
C14916,
5-Ethyl-5-phenyl-2,4-imidazolidinedione (9CI),
(+/-)-5-Ethyl-5-phenyl-2,4-imidazolidinedione,
(+/-)-5-ethyl-5-phenyl-imidazolidine-2,4-dione,
SR-01000317290,
2,4-Imidazolidinedione, 5-ethyl-5-phenyl- (9CI),
2,4-Imidazolidinedione, 5-ethyl-5-phenyl-, (R)-,
2,4-Imidazolidinedione, 5-ethyl-5-phenyl-, (S)-,
J-517475,
J-650236,
SR-01000317290-1,
Z56757176,
( inverted exclamation markA)-5-Ethyl-5-phenylhydantoin,
F0239-0674,
5-ethyl-2-hydroxy-5-phenyl-1,5-dihydro-4H-imidazol-4-one,
( inverted exclamation markA)-5-Ethyl-5-phenyl-2,4-imidazolidinedione,
(R)-(-)-Nirvanol,
UNII-23SM1FA1AK,
23SM1FA1AK,
C11H12N2O2,
CID91480,
AR-1G8130,
C11-H12-N2-O2,
2,4-Imidazolidinedione,5-ethyl-5-phenyl-,
ethylphenylhydantoin, 4-(11)C-labeled,
C014544,
65567-32-0,
65567-34-2,
67905-46-8,